Co-founder Prescribes New Course For Ailing PharmEasy
Description
From scrapping an IPO to scrambling for funds are PharmEasy's troubles from terminal or transient? What is the plan with profitable Thyrocare amidst the turmoil? Host Mugdha Variyar, ET Prime sits down for a candid conversation with Siddharth Shah CEO and Co-Founder of PharmEasy's parent company API Holdings. Siddharth Shah responds yo what went wrong for PharmEasy, and will a new prescription pacify the pain and lead to profitability, stave off competition, and help survive the funding winter?
You can follow our host Mugdha Variyar on her social media:
Twitter - https://twitter.com/Mugdha_Variyar
Linkedin - https://www.linkedin.com/in/mugdha-variyar-97387625/
Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Google Podcasts.
See omnystudio.com/listener for privacy information.
United States
